Acacia Pharma Group Plc
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Media
    • Press Releases
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholder Meetings
    • California Compliance statement
    • Contact
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Media
    • Press Releases
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholder Meetings
    • California Compliance statement
    • Contact
  • Contact

Transforming medicine

Advancing care

Home > News

29 April 2022

Publication of Annual Report and Financial Statements for the Year ended 31 December 2021

30 March 2022

Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022

29 March 2022

Scheme of Arrangement Information Sheet

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc. (Part 1 of 2)

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc (Part 2 of 2)

23 February 2021

Proposed Capital Raising

19 February 2021

Acacia Pharma Group plc - Results of Placing - EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities

18 February 2021

Acacia Pharma Group plc - Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS®

15 December 2020

Issues of New Ordinary Shares in Connection with the Byfavo™ Acquisition

14 August 2020

Proposed Capital Raising

14 August 2020

Acacia Pharma Prospectus: Issue of 12,500,000 New Ordinary Shares

13 August 2020

Acacia Pharma Group plc - Proposed Capital Raising by way of a Placing of New Ordinary Shares

24 March 2020

Issues of New Ordinary Shares in Connection with the BYFAVO™ Acquisition

24 March 2020

Acacia Pharma Prospectus: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition

  • 2022 (5)
Acacia Pharma Group Plc
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map

© 2025 Acacia Pharma Group Plc

(Registered in England and Wales No: 09759376)
Registered office address: The Officers’ Mess, Royston Road, Duxford, Cambridge CB22 4QH, UK

Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of the Acacia Pharma Group

Website by Instinctif Partners

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.